TR199901564T2 - Pharmaceutical dosage form that dissolves quickly and provides taste-masking. - Google Patents

Pharmaceutical dosage form that dissolves quickly and provides taste-masking.

Info

Publication number
TR199901564T2
TR199901564T2 TR1999/01564T TR9901564T TR199901564T2 TR 199901564 T2 TR199901564 T2 TR 199901564T2 TR 1999/01564 T TR1999/01564 T TR 1999/01564T TR 9901564 T TR9901564 T TR 9901564T TR 199901564 T2 TR199901564 T2 TR 199901564T2
Authority
TR
Turkey
Prior art keywords
dosage form
core
pharmaceutical dosage
masking
dissolves quickly
Prior art date
Application number
TR1999/01564T
Other languages
Turkish (tr)
Inventor
Itoh Akinori
Niwa Toshiyuki
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR199901564T2 publication Critical patent/TR199901564T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Abstract

Hizli çözülebilen ve tat maskelendirici ispençiyari dozaj formu aktif karisim ihtiva eden çekirdek, düsük sübsitüte edilmis hidroksipiropil selülöz, ve mikrokristalin selülöz, çekirdek toplam agirliginin en az %26.0'i mikrokristalin selülözden olusan; ve çekirdek, suda çözülebilir polimer ihtiva eden çekirdek üzerinde olusturulmus iç saran tabaka; tükürükte çözülmeyen polimer ihtiva eden iç saran tabakanin üzerinde olusturulmus dis saran tabakadan olusmaktir. Böyle bir oral dozaj formu hazirlanmasini saglayan islem açiklanmistir.The core, which contains a quick dissolving and taste-masking pharmaceutical dosage form active mixture, consists of low-supposed hydroxypropyl cellulose, and microcrystalline cellulose, and at least 26.0% of the core total weight is microcrystalline cellulose; and the core, the inner-wrapping layer formed on the core containing the water-soluble polymer; It consists of an outer enveloping layer formed on the inner enveloping layer containing the insoluble polymer in saliva. The process that enables the preparation of such an oral dosage form has been described.

TR1999/01564T 1997-01-06 1997-11-20 Pharmaceutical dosage form that dissolves quickly and provides taste-masking. TR199901564T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06

Publications (1)

Publication Number Publication Date
TR199901564T2 true TR199901564T2 (en) 1999-09-21

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01564T TR199901564T2 (en) 1997-01-06 1997-11-20 Pharmaceutical dosage form that dissolves quickly and provides taste-masking.

Country Status (36)

Country Link
EP (1) EP0941075B1 (en)
JP (1) JP3350059B2 (en)
KR (1) KR20000069899A (en)
CN (1) CN1244119A (en)
AP (1) AP802A (en)
AR (1) AR008553A1 (en)
AT (1) ATE238776T1 (en)
AU (1) AU715867B2 (en)
BG (1) BG103541A (en)
BR (1) BR9714253A (en)
CA (1) CA2277017C (en)
CO (1) CO4650099A1 (en)
DE (1) DE69721559T2 (en)
DK (1) DK0941075T3 (en)
EA (1) EA199900521A1 (en)
ES (1) ES2192265T3 (en)
HN (1) HN1997000151A (en)
HR (1) HRP980005A2 (en)
HU (1) HUP0002744A3 (en)
ID (1) ID21806A (en)
IL (1) IL130582A0 (en)
IS (1) IS5095A (en)
MA (1) MA26464A1 (en)
NO (1) NO993315L (en)
NZ (1) NZ336251A (en)
OA (1) OA11072A (en)
PA (1) PA8443301A1 (en)
PE (1) PE27999A1 (en)
PL (1) PL334439A1 (en)
SK (1) SK89599A3 (en)
TN (1) TNSN98002A1 (en)
TR (1) TR199901564T2 (en)
UY (1) UY24835A1 (en)
WO (1) WO1998030209A1 (en)
YU (1) YU31599A (en)
ZA (1) ZA9829B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834507A1 (en) * 1998-07-31 2000-02-03 Hexal Ag Pharmaceutical, water-soluble tablet formulation for the use of sildenafil
DE19834506A1 (en) * 1998-07-31 2000-02-03 Hexal Ag Transmucosal therapeutic system for the use of sildenafil
UA67802C2 (en) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
FR2795962B1 (en) * 1999-07-08 2003-05-09 Prographarm Laboratoires PROCESS FOR THE MANUFACTURE OF MASK TASTE COATED GRANULES AND IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
NZ524572A (en) 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (en) * 2001-07-20 2004-03-17 Novartis Ag PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
SE0202365D0 (en) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
EP1728791A4 (en) 2004-03-25 2008-12-10 Astellas Pharma Inc Composition for solid pharmaceutical preparation of solifenacin or salt thereof
BG66010B1 (en) * 2004-12-08 2010-10-29 "Софарма" Ад Medicamentous form of sildenafil
DE602006020642D1 (en) * 2005-01-06 2011-04-21 Cima Labs Inc Taste suppressant system for non-plasticized medicines
JPWO2007010930A1 (en) * 2005-07-20 2009-01-29 アステラス製薬株式会社 Drug-containing coated fine particles for orally disintegrating preparation and method for producing the same
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JP2007031407A (en) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd Coating composition containing cellulose ether with low substitution degree, and film-coated preparation with concealed unpleasant taste
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (en) * 2006-08-02 2010-12-22 和光堂株式会社 Coated particle-containing composition and method for producing the same
JPWO2008059881A1 (en) * 2006-11-14 2010-03-04 サンスター株式会社 Composition for oral cavity comprising crystalline cellulose surface-treated with water-soluble substance
JP5777273B2 (en) * 2008-07-10 2015-09-09 大正製薬株式会社 Formulation particles containing drug with unpleasant taste
JP4706785B2 (en) * 2008-09-30 2011-06-22 アステラス製薬株式会社 Particulate pharmaceutical composition for oral administration
US20110244050A1 (en) 2008-12-12 2011-10-06 Siegfried Rhein S.A. De C.V. Pulsed-release sildenafil composition and method for preparing said composition
DE102009016584A1 (en) 2009-04-06 2010-10-07 Ratiopharm Gmbh Orodispersible tablet containing a sildenafil salt
WO2011081199A1 (en) * 2009-12-28 2011-07-07 ニプロ株式会社 Oral preparation having improved quality
JP5226732B2 (en) * 2010-05-20 2013-07-03 エスエス製薬株式会社 Compression molding for hypnosis
TWI462739B (en) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Processes for preparing piperazinium salts of sildenafil-analogues and use thereof
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (en) * 2013-05-03 2014-03-12 湖北新济药业有限公司 Compound metal ion replenisher and preparation method thereof
WO2017146052A1 (en) * 2016-02-23 2017-08-31 ニプロ株式会社 Pharmaceutical composition particles, orally disintegrating preparation including same, and method for producing pharmaceutical composition particles
WO2020045456A1 (en) * 2018-08-28 2020-03-05 東和薬品株式会社 Drug-containing particle
CN113559070B (en) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 Preparation method of medicine suitable for pet cough
CN116139088B (en) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 Sildenafil citrate-containing dry suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (en) * 1987-04-16 1988-10-26 Towa Yakuhin Kk Fine granule having excellent releasing property of medicinally active ingredient and masked bitterness
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JP2576927B2 (en) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 Fine grain nucleus
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole

Also Published As

Publication number Publication date
CA2277017C (en) 2002-11-26
CA2277017A1 (en) 1998-07-16
YU31599A (en) 2000-03-21
HUP0002744A3 (en) 2001-01-29
MA26464A1 (en) 2004-12-20
PL334439A1 (en) 2000-02-28
ES2192265T3 (en) 2003-10-01
ID21806A (en) 1999-07-29
CN1244119A (en) 2000-02-09
NZ336251A (en) 2001-01-26
BG103541A (en) 2000-03-31
EP0941075A1 (en) 1999-09-15
NO993315D0 (en) 1999-07-05
ZA9829B (en) 1999-07-05
PA8443301A1 (en) 2000-05-24
PE27999A1 (en) 1999-03-12
AU4880897A (en) 1998-08-03
JP3350059B2 (en) 2002-11-25
WO1998030209A1 (en) 1998-07-16
HRP980005A2 (en) 1998-10-31
EP0941075B1 (en) 2003-05-02
DE69721559D1 (en) 2003-06-05
OA11072A (en) 2002-02-27
AP802A (en) 2000-01-21
TNSN98002A1 (en) 2005-03-15
SK89599A3 (en) 2000-12-11
AR008553A1 (en) 2000-01-19
NO993315L (en) 1999-07-05
HUP0002744A2 (en) 2000-12-28
KR20000069899A (en) 2000-11-25
CO4650099A1 (en) 1998-09-03
JP2000514830A (en) 2000-11-07
DK0941075T3 (en) 2003-07-14
DE69721559T2 (en) 2003-11-27
IL130582A0 (en) 2000-06-01
IS5095A (en) 1999-06-25
AU715867B2 (en) 2000-02-10
UY24835A1 (en) 2000-09-29
EA199900521A1 (en) 1999-12-29
BR9714253A (en) 2000-04-18
ATE238776T1 (en) 2003-05-15
HN1997000151A (en) 1997-12-20
AP9801173A0 (en) 1998-01-31

Similar Documents

Publication Publication Date Title
TR199901564T2 (en) Pharmaceutical dosage form that dissolves quickly and provides taste-masking.
TR199800902T2 (en) Pharmaceutical formulations.
CA2109623A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
IS2403B (en) Rapidly soluble formulations containing fish gelatine
HUP0203451A2 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
HUP9802221A2 (en) Antiparasitic marcfortines and paraherquamides
ATE226815T1 (en) MANUFACTURING OF MEDICINAL PRODUCTS
IS4146A (en) A pharmaceutical preparation for oral administration of proton pump blockers
ES2172239T3 (en) OSMOTIC SYSTEM OF LIBERATION OF PHARMACOS.
FI880100A (en) Method of Preparation of an Oral Therapeutic System for Dissolvable Active Substances
ATE247457T1 (en) STABLE MEDICINAL FORM WITH BENZIMIDAZOLE DERIVATIVES AS AN ACTIVE SUBSTANCE FOR ORAL ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
DE60123384D1 (en) DOSAGE FORM OF THE TYPE "CASE AND CORE" WITH AN ACTIVE COMPOSITION THAT FACES NEUTRAL ORDER
TR200002214T2 (en) Non-degradable micro-particles of omeprazole in the stomach, production processes and pharmaceutical preparations.
EP0983995A3 (en) Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
EP2260836A3 (en) Rapid release tablet with coated drug-containing core and surrounding taste masking layer
ATE260645T1 (en) AGITATION-INDEPENDENT PHARMACEUTICAL MULTIPLE-UNIT RETARD PREPARATIONS AND METHOD FOR THEIR PRODUCTION
SE8803822A (en)
DE50112438D1 (en) DENTAL CARE IN PORTION CAPSULES
IE65251B1 (en) Controlled release capsules
CA1096307A (en) Pharmaceutical preparations
GEP20043377B (en) Pharmaceutical Complex
RU93004785A (en) SOLID CAPSULES OF CITARABIN OXPHOSPHATE
CA2214923A1 (en) Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
HUP0100634A2 (en) Pharmaceutical preparations comprising pentaerytritol tetranitrate